Skip to content

Paraprofessional Treatment of Depression in Vietnam

Paraprofessional Treatment of Depression in Vietnam

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01006694
Enrollment
473
Registered
2009-11-03
Start date
2010-03-31
Completion date
2012-05-31
Last updated
2015-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Symptoms

Keywords

depression, collaborative care, Vietnam, behavioral activation

Brief summary

Trained para-professional health care workers will implement a stepped-care model of depression care in commune health stations in Vietnam.

Detailed description

This project focuses on evaluation of a collaborative care system for treatment of depression in Vietnam. This system involves training para-professional health care workers in a stepped-care model system of depression care to be implemented in commune health stations in Vietnam.

Interventions

OTHERBehavioral Activation + Medication

Psychoeducation, behavioral activation therapy, and medication delivered within a collaborative care model.

DRUGGuideline Antidepressant Medication

Guideline Antidepressant Medication, following the VN National Mental Health plan.

Sponsors

RAND
CollaboratorOTHER
Vanderbilt University
CollaboratorOTHER
Vietnam Veterans of America Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>=18 2. Depression Diagnosis

Exclusion criteria

active psychosis, mania, substance abuse, suicidal behaviors, cognitive impairment.

Design outcomes

Primary

MeasureTime frameDescription
Change across time (random effects slope) in depressive symptoms, as assessed by the PHQ-9 questionnaire0, 6, 12, 24 weeksThe PHQ-9 (Patient Health Questionnaire-9) assesses depressive symptoms, over the last two weeks. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.

Secondary

MeasureTime frameDescription
Change across time (random effects slope) in physical health, as assessed by the SF-12 questionnaire, Physical Health subscale0, 6, 12, 24 weeksThe SF-12 questionnaire, Physical Health subscale, assesses physical health functioning. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.
Change across time (random effects slope) in mental health, as assessed by the SF-12 questionnaire, Mental Health subscale0, 6, 12, 24 weeksThe SF-12 questionnaire, Mental Health subscale, assesses mental health functioning. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.
Change across time (random effects slope) in anxiety symptoms, as assessed by the GAD-7 questionnaire0, 6, 12, 24 weeksThe GAD-7 (General Anxiety Disorder-7) assesses anxiety symptoms, over the last two weeks. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.
Substantial improvement in depressive symptoms, as assessed by the PHQ-96, 12, 24 weeksRates of substantial symptomatic improvement (50% or greater reduction in PHQ-9 scores from baseline), to (a) 6 weeks, (b) 12 weeks, (c) 24 weeks.
Depression remission, as assessed by the PHQ-96, 12, 24 weeksDepression remission (PHQ-9\<5), at (a) 6 weeks, (b) 12 weeks, (c) 24 weeks.
Change across time (random effects slope) in behavioral activation skills and behaviors, as assessed by the BADS questionnaire.0, 6, 12, 24 weeksThe BADS (Behavioral Activation for Depression Scale) questionnaire assesses behavioral activation-related skills and behaviors. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026